Stay updated on Nivolumab Plus Ipilimumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab in Melanoma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The study record no longer includes “2015 (U.S. NIH Grant/Contract)” among its related terms. The site revision marker changes from v3.8.0 to v3.8.1.
    Difference
    0.1%
    Check dated 2026-11-21T10:21:33.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the CheckMate 401 advanced melanoma study is displayed, including study design, participant criteria, locations, outcome measures, publications, and supporting documents. The record also indicates that the study is completed and no longer recruiting.
    Difference
    89%
    Check dated 2026-11-07T10:59:28.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T09:55:52.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    A notice about NIH websites transitioning from the term “Artificial Intelligence” to “Super Intelligence” appears above the ClinicalTrials.gov page. The study record remains inaccessible with a 403 error.
    Difference
    1%
    Check dated 2026-10-24T10:30:13.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.1 to v3.7.2 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-17T12:18:46.000Z thumbnail image
  7. Check
    42 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-10T12:17:23.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Melanoma Clinical Trial page.